# Registry First Wave Pilot A Creatinine S2 Source Addition Founder Approval 2026-08-24 v0.1

Status: Founder Approved for Version Control / Creatinine Lifecycle Remains Proposed / Source-Verified Transition Not Yet Authorized

Founder: 蓝耀栋

Approval date: 2026-08-24

## 1. Purpose

This closeout records Founder approval of the exact C36 Review Packet and exact revised Creatinine Registry record. Approval is limited to version control of the NIDDK conversion-source content revision. It does not execute the Creatinine S2 lifecycle transition.

## 2. Repository Baseline

- Repository: /Users/lanyaodong/Documents/congtie-api
- Branch: main
- Approval baseline HEAD: 2c7c871d74267ad455f550db97cd068461d32490
- Approval baseline origin/main: 2c7c871d74267ad455f550db97cd068461d32490
- Initial staging: empty
- Approval date: 2026-08-24

## 3. C33 and S1 Lineage

| Artifact | SHA-256 |
| --- | --- |
| C33 Source-Verified Transition Plan | dd627b31e887553b85179da78f47a504ef7da5df8113b6154bbcee4ec5f70121 |
| C33 Transition Plan Founder Approval | d3d90474ef17233bd8dbe0b7cc39409db061c1b0ee30a45a0e088fe9dac2f0c8 |
| S1 Review Packet | 0ab06764555e9261f27dfd9c832d800385c1bb830530d72451b8e2377bdfc932 |
| S1 Founder Approval | 9b53c1fc77ae104d7f106af796eed345452de2f410a265a4a42646b1ab872418 |

C33 identified the missing exact conversion authority as a prerequisite for Creatinine S2. S1 source-verified only Height and Body Weight. Creatinine remained proposed.

## 4. Exact C36 Review Packet

Path:

agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_s2_source_addition_review_packet_2026_08_24.v0.1.md

SHA-256:

671654fc947a7c39bd915f44d12a049eda6697bfe098fc18b904afe39a987c44

The packet retains its historical Draft / Founder Review Pending state because Founder approval applies to its exact reviewed bytes.

## 5. Creatinine SHA Before

Committed baseline SHA-256:

fa6b2ad250c6c1f8f2e4df6428970eebd5e6497061533f110dabe99c0549cbab

## 6. Creatinine SHA After

Approved revised SHA-256:

c8fd286a46334e2f9a4856503de37ff5d8f5dcdfc7128f8e5a7308ae75ae0fa6

Path:

agent/biomarker_measurement_registry/records/BM-000023.creatinine.json

## 7. Exact NIDDK Source Identity

- Source key: src-niddk-creatinine-conversion
- Title: eGFR Equations for Adults
- Organization: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- URL: https://www.niddk.nih.gov/research-funding/research-programs/kidney-clinical-research-epidemiology/laboratory/glomerular-filtration-rate-equations/adults
- Source role: other_reviewed_role
- Verification status: content_verified
- Access date retained in approved record: 2026-08-24
- Page last reviewed: May 2025

The official page was re-opened before commit preparation. Its title, organization, standardized SCr context, conversion factor, and last-reviewed date remained materially unchanged.

## 8. Exact Conversion Statement

The NIDDK page states:

> serum creatinine µmol/L to mg/dL, divide by 88.4

## 9. Exact Inverse Registry Rule

The approved Registry rule is the algebraic inverse:

value_mg/dL * 88.4 = value_umol/L

The formula and conversion_verified value were not changed by C36.

## 10. Exact SourceReference Approval

Founder approves this exact SourceReference object:

~~~json
{
  "source_key": "src-niddk-creatinine-conversion",
  "title": "eGFR Equations for Adults",
  "organization_or_journal": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
  "authors": [],
  "publication_date": null,
  "source_type": null,
  "source_role": "other_reviewed_role",
  "supports": [
    "serum creatinine unit conversion using factor 88.4 between umol/L and mg/dL",
    "standardized serum creatinine input context for adult eGFR equations"
  ],
  "does_not_support": [
    "assay or platform equivalence",
    "reference interval",
    "diagnosis",
    "personal target or action"
  ],
  "url": "https://www.niddk.nih.gov/research-funding/research-programs/kidney-clinical-research-epidemiology/laboratory/glomerular-filtration-rate-equations/adults",
  "doi": null,
  "pmid": null,
  "access_date": "2026-08-24",
  "verification_status": "content_verified",
  "note": "Official unit-conversion authority; page last reviewed May 2025."
}
~~~

## 11. Exact Profile Source-Link Approval

Founder approves the exact final Profile source-reference sequence:

~~~json
[
  "src-nist-creat",
  "src-creat-method-2020",
  "src-wst4045",
  "src-niddk-creatinine-conversion"
]
~~~

The NIDDK source is not added to definition_source_keys, LOINC mappings, concept external mappings, ReferenceContext, or UseEvidenceClaim.

## 12. Current-Schema Linkage Rationale

The NIDDK source is linked to the current enzymatic Creatinine Profile because the supported conversion rule is represented inside that Profile's `accepted_units`, and the current Registry Schema provides source linkage at concept and Profile level. This linkage does not mean the factor `88.4` is specific to an enzymatic assay and does not establish assay, platform or laboratory equivalence.

This rationale does not modify the Profile method, method comparability, cross-platform comparison prohibition, conversion rule, SourceReference support scope, or Profile limitations.

## 13. Source-Count Change

~~~text
SourceReference count: 6 -> 7
New source objects: 1
Duplicate source keys: 0
Profile source-key count: 3 -> 4
definition_source_keys changes: 0
mapping source-key changes: 0
~~~

## 14. Governance-Date Changes

~~~text
governance_metadata.last_modified_date:
2026-08-23 -> 2026-08-24

governance_metadata.last_source_check_date:
2026-08-22 -> 2026-08-24
~~~

created_date, reviewed_by, reviewed_date, and status_note remain unchanged.

## 15. Deep-Diff Result

~~~text
Added SourceReference objects = 1
Added Profile source-key references = 1
Changed existing scalar leaves = 2
Removed keys = 0
Reordered arrays = 0
Unauthorized changes = 0
~~~

Result: PASS

## 16. Schema and Validator Results

- JSON syntax: PASS
- Draft 2020-12 Schema: PASS
- Permanent Validator: VALID
- Candidate Ledger lineage: PASS
- Content checks: 20/20 PASS
- Exact source-object checks: PASS
- Warnings: 0
- Errors: 0

## 17. Version Decision

Founder approves keeping:

version: v0.1

The revision adds exact provenance for an existing conversion rule. It does not change construct identity, Profile boundary, method, accepted units, formula, mappings, limitations, or Agent permissions.

## 18. Lifecycle State

The approved post-commit Registry state remains:

~~~text
Creatinine RegistryConcept.lifecycle_status = proposed
creatinine.serum_or_plasma.enzymatic.profile_status = proposed
~~~

No source_verified, human_reviewed, active, runtime, retrieval, or publication transition is included.

## 19. Exact Approval Language

Founder approves the exact SHA-identified Creatinine content revision that adds the NIDDK unit-conversion SourceReference and links it to `creatinine.serum_or_plasma.enzymatic`. The revised record remains `version: v0.1`, with RegistryConcept and Profile lifecycle both remaining `proposed`. This approval does not execute the Creatinine S2 source-verified transition and does not authorize human review, active status, publication, runtime, retrieval, diagnosis, treatment, personal targets or action.

## 20. Founder Decisions

~~~text
Decision 1: NIDDK SourceReference = Approved
Decision 2: Profile source linkage = Approved
Decision 3: version v0.1 = Approved
Decision 4: revised record SHA = Approved
Decision 5: controlled commit/push without lifecycle transition = Approved

Founder decisions approved = 5/5
Founder pending decisions = 0
~~~

## 21. Explicit Non-Authorizations

This approval does not authorize:

- Creatinine RegistryConcept or Profile source_verified transition;
- human-reviewed or active lifecycle;
- Heart Rate S3;
- claims, thresholds, reference contexts, system relations, lifecycle relations, or device mappings;
- changes to formula, conversion_verified, method, mapping, units, Profile boundary, interpretation limitations, or Agent permissions;
- runtime, retrieval, publication, database, API, loader, index, Observation processing, or user-health storage;
- diagnosis, treatment, personal targets, or action.

## 22. Exact Registry State

~~~text
Height concept/Profile = source_verified
Body Weight concept/Profile = source_verified

Creatinine RegistryConcept = proposed
creatinine.serum_or_plasma.enzymatic = proposed
Creatinine source count = 7

Heart Rate RegistryConcept and both Profiles = proposed

Human-reviewed lifecycle records = 0
Active records = 0
Runtime-enabled records = 0
Retrieval-enabled records = 0
Published records = 0
User observations = 0
~~~

## 23. Git Commit Plan

Commit A:

- Message: feat: add NIDDK conversion provenance to Creatinine Registry record
- Manifest: agent/biomarker_measurement_registry/records/BM-000023.creatinine.json

Commit B:

- Message: docs: approve Creatinine conversion-source revision
- Manifest: C36 Review Packet and this Founder approval closeout

One normal push to origin/main follows a remote-movement Gate. No amend, squash, rebase, force push, or tag push is authorized.

## 24. Next S2 Lifecycle Gate

After this exact content revision and approval closeout are versioned, the only recommended next task is:

Step5-C38: Execute Creatinine Source Transition S2

C38 requires separate authorization before changing:

~~~text
Creatinine RegistryConcept:
proposed -> source_verified

creatinine.serum_or_plasma.enzymatic:
proposed -> source_verified
~~~

No lifecycle transition is executed by this approval closeout.
